异动解读 | Apellis Pharmaceuticals Inc. (APLS) 盘前大涨9.62%,2024年Q4财报超预期

异动解读
28 Feb

生物制药公司Apellis Pharmaceuticals Inc. (APLS)今日盘前交易中大涨9.62%,引发市场关注。

公司此前公布的2024年第四季度财报数据显示,其每股亏损为0.29美元,优于分析师预期的0.37美元;季度销售额2.1253亿美元,也超过了分析师预期的1.9835亿美元。

出色的财报业绩提振了投资者信心,令公司股价在盘前交易中大涨。市场预计Apellis Pharmaceuticals未来业绩或将持续向好,公司在生物医药领域的前景备受看好。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10